Ernal, Ethan Jay D.
HRN: 22-70-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/13/2023
03/19/2023
IV
110mg
OD
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes